Vector-borne diseases (VBDs) represent a significant challenge to public health in India. The country's vast geographical diversity and climatic variations create an environment conducive to the spread of various vectors, leading to a high disease burden.
India is currently grappling with a multitude of VBDs including malaria, dengue, chikungunya, and Japanese encephalitis. Malaria alone accounts for a significant portion of the disease burden, with the World Health Organisation estimating around 6.7 million cases in 2018. Additionally, the increasing incidence of dengue and chikungunya pose a substantial threat to public health.
The fight against VBDs in India is fraught with challenges. These include the lack of effective vector control strategies, inadequate healthcare infrastructure, and gaps in disease surveillance. Additionally, the effects of climate change, urbanisation, and population mobility further exacerbate the situation.
Effective control of VBDs necessitates a multi-pronged approach. This includes strengthening surveillance systems, improving diagnostic capabilities, and implementing effective vector control strategies. In addition, increasing community awareness and participation, and fostering intersectoral coordination are crucial. The recent launch of the National Vector Borne Disease Control Programme (NVBDCP) is a step in the right direction, aiming to reduce the morbidity and mortality associated with VBDs.
Vector-borne diseases pose a significant public health challenge in India. While the situation is daunting, a concerted effort involving the government, healthcare professionals, and the community can make a significant difference. By strengthening healthcare infrastructure, improving surveillance, and implementing effective control strategies, India can turn the tide against these diseases. The battle is far from over, but with a comprehensive and coordinated approach, victory is within reach.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation